| |
| |
|
| Insider
Information: |
Hack Andrew A. F. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
25,181 |
|
|
Indirect Shares
|
18,379,099 |
|
|
| Direct
Value |
$173,893 |
|
|
|
Indirect Value
|
$44,775,841 |
|
|
| Total
Shares |
18,404,280 |
|
|
| Total
Value |
$44,949,734 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
20
|
7
|
|
Stock
price went up :
|
17
|
3
|
| Stock
price went down : |
3
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
5.7
|
5.7
|
| Percentage
Gain/Loss : |
 61.2%
|
 -72.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Editas Medicine, Inc. |
EDIT |
Chief Financial Officer |
2019-02-04 |
0 |
2017-02-15 |
0 |
Premium* |
|
|
Dynavax Technologies Corp |
DVAX |
|
2023-08-08 |
10,714 |
2023-08-08 |
915,000 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
Director |
2023-06-08 |
14,467 |
2023-06-08 |
8,663,673 |
Premium* |
|
|
Bcls Acquisition Corp. |
BLSA |
Chief Financial Office... |
2020-10-26 |
0 |
2020-10-26 |
487,500 |
Premium* |
|
|
Atea Pharmaceuticals, Inc. |
AVIR |
Director |
2020-11-03 |
0 |
2020-11-03 |
5,615,659 |
Premium* |
|
|
Nuvalent, Inc. |
NUVL |
|
2021-08-02 |
0 |
2024-03-27 |
2,697,267 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DVAX |
Dynavax Technologies Corp |
Director |
– • – |
2019-08-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,525,000 |
|
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-02-15 |
4 |
OE |
$3.23 |
$9,690 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-02-15 |
4 |
AS |
$19.20 |
$57,600 |
D/D |
(3,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-11-17 |
4 |
OE |
$3.23 |
$16,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-11-17 |
4 |
AS |
$24.81 |
$124,073 |
D/D |
(5,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-11-20 |
4 |
OE |
$3.23 |
$16,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-11-20 |
4 |
AS |
$25.35 |
$126,732 |
D/D |
(5,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-15 |
4 |
OE |
$3.23 |
$16,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-15 |
4 |
AS |
$24.31 |
$121,546 |
D/D |
(5,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-18 |
4 |
AS |
$24.68 |
$123,409 |
D/D |
(5,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-18 |
4 |
OE |
$3.23 |
$16,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-19 |
4 |
OE |
$3.23 |
$15,016 |
D/D |
4,649 |
4,649 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-19 |
4 |
AS |
$25.06 |
$116,510 |
D/D |
(4,649) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-14 |
4 |
OE |
$6.48 |
$38,880 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-14 |
4 |
AS |
$32.71 |
$196,260 |
D/D |
(6,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-15 |
4 |
OE |
$6.48 |
$38,880 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-15 |
4 |
AS |
$34.61 |
$207,660 |
D/D |
(6,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-16 |
4 |
AS |
$35.32 |
$211,920 |
D/D |
(6,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-16 |
4 |
OE |
$6.48 |
$38,880 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-16 |
4 |
OE |
$6.48 |
$38,880 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-16 |
4 |
AS |
$39.43 |
$236,580 |
D/D |
(6,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-19 |
4 |
OE |
$6.48 |
$38,880 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-19 |
4 |
AS |
$37.65 |
$225,900 |
D/D |
(6,000) |
0 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-20 |
4 |
OE |
$6.48 |
$580,080 |
D/D |
28,000 |
22,000 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-20 |
4 |
AS |
$37.51 |
$1,059,960 |
D/D |
(28,000) |
0 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
